Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-part, Phase 1, First-Time-in-Human Study to Investigate Safety, Tolerability, and PK of VH4770359 in Healthy Participants

NCT07525544 is registered in ClinicalTrials.gov with ViiV Healthcare as lead sponsor.

NCT NCT07525544
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07525544 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-part, Phase 1, First-Time-in-Human Study to Investigate Safety, Tolerability, and PK of VH4770359 in Healthy Participants
Lead sponsor
ViiV Healthcare
Phase
Phase 1
Overall status
Recruiting
Start date
May 14, 2026
Completion date
May 5, 2027
Enrollment
214 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections